Cargando…

MicroRNA-21 induces cisplatin resistance in head and neck squamous cell carcinoma

Drug resistance, either intrinsic or acquired, can impair treatment effects and result in increased cell motility and death. MicroRNA-21 (miR-21), a proto-oncogene, may facilitate the development or maintenance of drug resistance in cancer cells. Restoring drug sensitivity can improve therapeutic st...

Descripción completa

Detalles Bibliográficos
Autores principales:	Sheng, Shuyan, Su, Wenzhuo, Mao, Deshen, Li, Conghan, Hu, Xinyang, Deng, Wanyu, Yao, Yong, Ji, Yongsheng
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Public Library of Science 2022
Materias:	Research Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9009694/ https://www.ncbi.nlm.nih.gov/pubmed/35421166 http://dx.doi.org/10.1371/journal.pone.0267017

Ejemplares similares

The role of resveratrol on rheumatoid arthritis: From bench to bedside
por: Sheng, Shuyan, et al.
Publicado: (2022)

MicroRNAs as the pivotal regulators of cisplatin resistance in head and neck cancers
por: Tolue Ghasaban, Faezeh, et al.
Publicado: (2023)

Integrated analysis of deregulation microRNA expression in head and neck squamous cell carcinoma
por: Qi, Cheng-Lin, et al.
Publicado: (2021)

MicroRNA Deregulations in Head and Neck Squamous Cell Carcinomas
por: Chen, Dan, et al.
Publicado: (2013)

MicroRNA as a Novel Modulator in Head and Neck Squamous Carcinoma
por: Chen, Li-Hsin, et al.
Publicado: (2010)

MicroRNAs and cell proliferation in head and neck squamous cell carcinoma
por: Andreghetto, Flavia M, et al.
Publicado: (2013)

A Pan-Cancer Analysis of the Oncogenic Role of Cell Division Cycle-Associated Protein 4 (CDCA4) in Human Tumors
por: Fang, Hui, et al.
Publicado: (2022)

The Role of MicroRNAs in Recurrence and Metastasis of Head and Neck Squamous Cell Carcinoma
por: Yang, Chris X., et al.
Publicado: (2019)

MicroRNAs in Head and Neck Cancer
por: John, Keziah, et al.
Publicado: (2013)

MicroRNAs in Head and Neck Squamous Cell Carcinoma (HNSCC) and Oral Squamous Cell Carcinoma (OSCC)
por: Shiiba, Masashi, et al.
Publicado: (2010)

Decitabine Rescues Cisplatin Resistance in Head and Neck Squamous Cell Carcinoma
por: Viet, Chi T., et al.
Publicado: (2014)

MicroRNA Profiling and Head and Neck Cancer
por: Liu, Xiqiang, et al.
Publicado: (2009)

MicroRNA expression profiles of cancer stem cells in head and neck squamous cell carcinoma
por: YATA, KAZUYA, et al.
Publicado: (2015)

MicroRNA-141 suppresses growth and metastatic potential of head and neck squamous cell carcinoma
por: Zhao, Zhiguo, et al.
Publicado: (2019)

Expanding the Transcriptome of Head and Neck Squamous Cell Carcinoma Through Novel MicroRNA Discovery
por: Rock, Leigha D., et al.
Publicado: (2019)

Accuracy of microRNAs as markers for the detection of neck lymph node metastases in patients with head and neck squamous cell carcinoma
por: de Carvalho, Ana Carolina, et al.
Publicado: (2015)

Metoclopramide enhances the effect of cisplatin on xenografted squamous cell carcinoma of the head and neck.
por: KjellÃ©n, E., et al.
Publicado: (1989)

Mechanisms of Cisplatin Resistance in HPV Negative Head and Neck Squamous Cell Carcinomas
por: Griso, Ana Belén, et al.
Publicado: (2022)

Chemoradiation with Cisplatin vs. Carboplatin for Squamous Cell Carcinoma of the Head and Neck (SCCHN)
por: Rades, Dirk, et al.
Publicado: (2023)

MicroRNAs: Their Role in Metabolism, Tumor Microenvironment, and Therapeutic Implications in Head and Neck Squamous Cell Carcinoma
por: Shiah, Shine-Gwo, et al.
Publicado: (2021)

More than a Bubble: Extracellular Vesicle microRNAs in Head and Neck Squamous Cell Carcinoma
por: Panvongsa, Wittaya, et al.
Publicado: (2022)

The prognostic value of MicroRNAs associated with fatty acid metabolism in head and neck squamous cell carcinoma
por: Wang, Xiaojing, et al.
Publicado: (2022)

MicroRNAs Involvement in Radioresistance of Head and Neck Cancer
por: Ahmad, Parwez, et al.
Publicado: (2017)

Erratum: Accuracy of microRNAs as markers for the detection of neck lymph node metastases in patients with head and neck squamous cell carcinoma
por: de Carvalho, Ana Carolina, et al.
Publicado: (2015)

MicroRNA-21 promotes head and neck squamous cell carcinoma (HNSCC) induced transition of bone marrow mesenchymal stem cells to cancer-associated fibroblasts
por: Wang, Hao, et al.
Publicado: (2023)

MicroRNA-21 Increases Proliferation and Cisplatin Sensitivity of Osteosarcoma-Derived Cells
por: Vanas, Vanita, et al.
Publicado: (2016)

Eligibility criteria to cisplatin in head and neck squamous cell carcinoma: Egyptian expert opinion
por: Abdulla, Mohamed, et al.
Publicado: (2023)

Transcriptomic and Proteomic Profiles for Elucidating Cisplatin Resistance in Head-and-Neck Squamous Cell Carcinoma
por: Garcia-Mayea, Yoelsis, et al.
Publicado: (2022)

A Signature Based on Costimulatory Molecules for the Assessment of Prognosis and Immune Characteristics in Patients With Stomach Adenocarcinoma
por: Chen, Bangjie, et al.
Publicado: (2022)

Synthetic Evaluation of MicroRNA-1-3p Expression in Head and Neck Squamous Cell Carcinoma Based on Microarray Chips and MicroRNA Sequencing
por: Chen, Yubing, et al.
Publicado: (2021)

Prognostic microRNA signatures derived from The Cancer Genome Atlas for head and neck squamous cell carcinomas
por: Wong, Nathan, et al.
Publicado: (2016)

Genome-scale identification of microRNA-related SNPs associated with risk of head and neck squamous cell carcinoma
por: Wilkins, Owen M, et al.
Publicado: (2017)

Bioinformatics analysis of the expression and role of microRNA-221-3p in head and neck squamous cell carcinoma
por: Zhou, Ziyan, et al.
Publicado: (2021)

MicroRNA-21 Contributes to Liver Regeneration by Targeting PTEN
por: Chen, Xiaoyu, et al.
Publicado: (2016)

microRNA evaluation of unknown primary lesions in the head and neck
por: Barker, Emma V, et al.
Publicado: (2009)

DNA-Bound Platinum Is the Major Determinant of Cisplatin Sensitivity in Head and Neck Squamous Carcinoma Cells
por: Martens-de Kemp, Sanne R., et al.
Publicado: (2013)

Feasibility of Cisplatin/5-Fluorouracil and Panitumumab in Japanese Patients with Squamous Cell Carcinoma of the Head and Neck
por: Tahara, Makoto, et al.
Publicado: (2014)

Weekly Docetaxel, Cisplatin, and Cetuximab in Palliative Treatment of Patients with Squamous Cell Carcinoma of the Head and Neck
por: Trieu, Vanessa, et al.
Publicado: (2018)

Feasibility of concomitant cisplatin with hypofractionated radiotherapy for locally advanced head and neck squamous cell carcinoma
por: Jacinto, Alexandre Arthur, et al.
Publicado: (2018)

Diagnostic and Prognostic Value of MicroRNAs in Metastasis and Recurrence of Head and Neck Squamous Cell Carcinoma: A Systematic Review and Meta-Analysis
por: Qiu, Ke, et al.
Publicado: (2021)

Cannot write session to /tmp/vufind_sessions/sess_jr3ua4eet9h63n2bcn8fe97qra